Search results
Lilly’s Weight-Loss Drug Is a Huge Hit. Its CEO Wants to Replace It ASAP.
The Wall Street Journal· 3 hours agoJust a year and a half later, it was approved as Zepbound for chronic weight management. “I’m pretty...
NHS and ABPI announce new guidelines ahead of UK elections
Pharmaceutical Technology via Yahoo Finance· 11 hours agoIt highlights how partnerships can be formed between local NHS organisations and the pharmaceutical...
Insider Sale: Director Julie Mchugh Sells Shares of Ironwood Pharmaceuticals Inc (IRWD)
GuruFocus.com via Yahoo Finance· 1 day agoFollowing this transaction, the insider now owns 139,528 shares of Ironwood Pharmaceuticals Inc....
Cranbury Pharmaceuticals Receives FDA Approval for First Generic Version of Emflaza Oral Suspension
New Jersey Business Magazine· 22 hours agoCranbury Pharmaceuticals, a wholly-owned subsidiary of Tris Pharma, today announced the U.S. Food...
Exploring Novartis And Two More High-Yield Dividend Stocks In Switzerland
Simply Wall St. via Yahoo Finance· 45 minutes agoThe Switzerland market recently experienced a moderate decline, influenced by investor concerns that...
B. Riley Increases Longboard Pharmaceuticals (NASDAQ:LBPH) Price Target to $36.00
ETF DAILY NEWS· 2 days agoLongboard Pharmaceuticals (NASDAQ:LBPH – Free Report) had its price target hoisted by B. Riley from $30.00 to $36.00 in a report released on Tuesday, Benzinga reports. The ...
A New Drug Could Slow Alzheimer's. But Can Patients Get It?
Bloomberg· 2 days agoA New Drug Could Slow Alzheimer's. But Can Patients Get It? A new medicine from Eli Lilly will face...
Mark C. Schneyer Sells 975 Shares of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Stock
ETF DAILY NEWS· 21 hours agoACADIA Pharmaceuticals Inc. (NASDAQ:ACAD – Get Free Report) CFO Mark C. Schneyer sold 975 shares of the company’s stock in a transaction that occurred on Monday, June 10th ...
Longboard Pharmaceuticals (NASDAQ:LBPH) Stock Rating Reaffirmed by HC Wainwright
ETF DAILY NEWS· 1 day agoLongboard Pharmaceuticals (NASDAQ:LBPH – Get Free Report)‘s stock had its “buy” rating reissued by equities research analysts at HC Wainwright in a research report issued ...
Editorial: Supreme Court keeps medication abortion safe — for now
Los Angeles Times Opinion via Yahoo News· 7 hours agoThe Supreme Court on Thursday ruled against a challenge to mifepristone, one of the two ...